基于多孔底物的电穿孔与跨上皮电阻抗监测
2024年9月27日
多孔底物电穿孔 （PSEP） 将一致、高通量的递送与高细胞活力配对。跨上皮电阻抗 （TEEI） 测量的引入提供了对 PSEP 中间过程的深入了解，并允许无标记交付。本文讨论了一种同时进行 PSEP 递送实验和 TEEI 测量分析的方法。
我们的研究重点是改进多孔基材电穿孔。研究表明，使用微通道和纳米通道定位电穿孔具有重大优势。但仍有一些问题需要回答，尤其是在过程的中间阶段监测和表征效应。
一些最新的发展包括我们使用跨上皮电阻抗监测，以及使用基于纳米通道的电穿孔来创建外泌体或测量细胞膜中的张力。PSEP 实验仍然严重依赖荧光成像前后来确定递送和细胞活力结果。此外，许多基于 PSEP 的研究报告了脉冲参数，而很少有研究来验证常见细胞类型的最佳参数。
我们解决的主要研究差距是缺乏关于 PSEP 在细胞恢复阶段影响的报告。然而，我们对 TEEI 测量的分析将 TEEI 变化与活力和递送效率相关联，这也使我们能够确定最佳的 PSEP 波形参数。我们前进的主要重点是确定导致 TEEI 增加的机制。
理想情况下，这些发现将帮助我们微调 PSEP 流程，以实现更高效的交付。
概述
本文讨论了多孔基底电穿孔（PSEP）的进展以及转上皮电阻（TEEI）测量的引入。这些创新在保持高细胞活力的同时增强了传递过程，并为PSEP的中间阶段提供了洞察。
关键研究组成部分
科学领域
- 神经科学
- 细胞生物学
- 电穿孔技术
背景
- 多孔基底电穿孔提供了高通量传递。
- 微米和纳米通道被用于在电穿孔过程中改善定位。
- 传统方法依赖于荧光成像来评估传递结果。
- 缺乏关于各种细胞类型的最佳脉冲参数的研究。
研究目的
- 改善对细胞恢复阶段PSEP的理解。
- 使用TEEI测量来表征电穿孔的影响。
- 提供同时进行PSEP传递和TEEI分析的方法。
使用的方法
- 多孔基底电穿孔实验。
- 转上皮电阻测量。
- 电穿孔后细胞活力分析。
- 电穿孔过程中中间过程的表征。
主要结果
- TEEI测量为PSEP过程提供了宝贵的洞察。
- 在传递过程中保持高细胞活力。
- 同时分析增强了对电穿孔效应的理解。
- 研究发现了脉冲参数及其效应报告中的空白。
结论
- 该研究推进了PSEP和TEEI测量的方法论。
- 研究结果有助于优化电穿孔技术。
- 未来的研究应关注细胞恢复期间的效应。
常见问题
Executive Industry Relevance
Porous substrate-based electroporation (PSEP) with integrated transepithelial electrical impedance (TEEI) monitoring addresses a critical gap in intracellular delivery workflows by enabling real-time, quantitative assessment of delivery efficiency and cell viability. This dual-readout approach enhances predictive confidence at the target validation and assay development stages, supporting risk-adjusted decision-making and portfolio triage. The method's ability to correlate electrical impedance changes with delivery outcomes positions it as a valuable tool for optimizing electroporation parameters and reducing mechanistic ambiguity in early discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables quantitative interrogation of delivery efficiency and cell viability during electroporation.
- Supports mechanistic de-risking by correlating TEEI changes with biological outcomes.
- Facilitates identification of optimal waveform parameters for functional target validation.
- Improves predictive confidence for advancing delivery technologies in discovery portfolios.
Screening & Assay Development
- Provides standardized, reproducible delivery conditions for assay-ready cell monolayers.
- Enables real-time monitoring of cell health and delivery success prior to downstream screening.
- Supports scalability and platform reuse by leveraging commercially available inserts and quantitative readouts.
- Enhances reliability of compound evaluation by integrating impedance-based viability metrics.
Translational & Preclinical Research
- Aligns delivery efficiency and viability metrics with translational biomarker requirements when relevant.
- Supports continuity from discovery through preclinical validation by providing mechanistic insight into delivery processes.
- Reduces risk of late-stage failure by enabling early detection of suboptimal delivery conditions.
Pipeline & Workflow Integration
PSEP with TEEI monitoring integrates into the discovery-to-preclinical continuum by providing actionable data at the delivery optimization and assay development inflection points.
- Discovery Biology: Supports hypothesis testing and pathway clarification through quantitative delivery and viability assessment.
- Screening: Delivers reproducible, assay-ready cell systems with validated delivery metrics.
- Analytics: Provides impedance-based measurements and fluorescent readouts for robust condition comparison.
- Translational Research: Offers mechanistic de-risking and supports biomarker alignment when delivery efficiency is critical.
- Enterprise Reuse: Establishes a reusable, standardized workflow for electroporation-based delivery optimization.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in delivery optimization.
- Operational Value: Enhances standardization, reproducibility, and scalability of electroporation workflows.
- Strategic Value: Enables better go/no-go decisions and capital efficiency by providing early, quantitative delivery metrics.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of delivery technologies.
Implementation Considerations
- Requires expertise in electroporation, impedance measurement, and quantitative fluorescence analysis.
- Needs access to PSEP devices, impedance monitoring systems, and fluorescence microscopy infrastructure.
- Demands cross-team standardization of pulse parameters and data reporting for reproducibility.
- May require adaptation of workflow for different cell types or model systems.
- Dependent on robust correlation between TEEI changes and delivery/viability metrics as supported by source data.
